2025/07/09 Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy
2025/07/01 ReproNovo Announces First Participant Included in U.S. Phase 2 Trial of RPN-001 for Male Infertility RPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low serum testosterone
2025/07/09 Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy
2025/07/01 ReproNovo Announces First Participant Included in U.S. Phase 2 Trial of RPN-001 for Male Infertility
2025/05/21 ReproNovo raises $65 Million Series A Financing to advance phase 2 clinical trials of novel therapies in reproductive medicine and Womens's Health
2025/05/01 Enara Bio Strengthens Senior Leadership with Key Executive and Board Appointments Alongside Acceleration of Multiple T-Cell Engager Programs
2025/04/15 Corvic AI Raises $12M in Seed Funding to Pioneer AI Cognitive Infrastructure for Enterprise Intelligence
2025/03/12 Celestial AI Secures $250 Million Funding to Revolutionize AI Infrastructure with Its Photonic Fabric
2025/03/05 TRIMTECH Therapeutics raises $31M to advance targeted protein degradation for treatment of neurodegenerative diseases
2025/01/21 NovoLINC Secures Investments to Assist AI Computing with Groundbreaking Thermal Interface Technology
2025/01/16 Outrun Therapeutics expands leadership team with appointment of Matthew Fyfe as Chief Scientific Officer
2025/01/13 Ribometrix Strengthens Leadership by appointing William S. Marshall as CEO and Katie Warner as CSO